These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 18761785

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
    Sison J, Assaad-Khalil SH, Najem R, Kitchlew AR, Cho B, Ueng KC, Shete A, Knap D.
    Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension.
    Lai WT, Park JE, Dongre N, Wang J.
    Adv Ther; 2011 May; 28(5):427-38. PubMed ID: 21491172
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
    Drummond W, Sirenko YM, Ramos E, Baek I, Keefe DL.
    Am J Cardiovasc Drugs; 2011 Oct 01; 11(5):327-33. PubMed ID: 21846154
    [Abstract] [Full Text] [Related]

  • 32. Antihypertensive effects of valsartan/hydrochlorothiazide combination in essential hypertension.
    Schmidt A, Adam SA, Kolloch R, Weidinger G, Handrock R.
    Blood Press; 2001 Oct 01; 10(4):230-7. PubMed ID: 11800062
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT, Hung YJ, Chen JF, Wang CY, Lee WJ, Sheu WH.
    Clin Ther; 2012 Aug 01; 34(8):1735-50. PubMed ID: 22784975
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination.
    Schweizer J, Hilsmann U, Neumann G, Handrock R, Klebs S.
    Curr Med Res Opin; 2007 Nov 01; 23(11):2877-85. PubMed ID: 17922981
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers.
    Fuenfstueck R, Hempel RD, Ansari A, Weidinger G, Klebs S.
    Adv Ther; 2005 Nov 01; 22(3):263-77. PubMed ID: 16236687
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.